lestaurtinib has been researched along with Cholera Infantum in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baer, MR; Basu, T; Demakos, EP; Goldberg, JD; Hexner, EO; Hoffman, R; Jeschke, G; Kleczko, J; Leibowitz, D; Marchioli, R; Mascarenhas, J; Miller, C; Najfeld, V; Orazi, A; Pahl, HL; Prchal, J; Price, L; Ritchie, EK; Roboz, GJ; Silverman, LR; Siuty, J; Weinberg, R | 1 |
1 trial(s) available for lestaurtinib and Cholera Infantum
Article | Year |
---|---|
Phase I dose escalation study of lestaurtinib in patients with myelofibrosis.
Topics: Adult; Aged; Aged, 80 and over; Carbazoles; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Furans; Gastrointestinal Diseases; Humans; Janus Kinase 2; Leukopenia; Male; Middle Aged; Mutation, Missense; Primary Myelofibrosis; Treatment Outcome; Young Adult | 2015 |